Currently, anti-IL-6 or IL-6R therapy is used worldwide in various autoimmune diseases, such as rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA), systemic sclerosis, and uveitis [34]. This evidence concerns the gene IL6R and juvenile idiopathic arthritis.